The Europe clinical trial management market growth is expected to progress at a CAGR of 13.00% during the forecast period, 2022-2030. The high number of clinical trials conducted, the availability of trained professionals, and the growing demand for novel drugs for chronic disease treatment propel market growth.

EUROPE CLINICAL TRIAL MANAGEMENT MARKET FORECAST 2022-2030

Europe Clinical Trial Management Market by End-user (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers) Market by Product Type (Enterprise-based CTM, Site-based CTM) Market by Deployment Model (Web-based Deployment, on-premise Deployment, Cloud-based Deployment) Market by Component (Software, Hardware, Services) by Geography

Request free sample

The Europe clinical trial management market growth is expected to progress at a CAGR of 13.00% during the forecast period, 2022-2030. The high number of clinical trials conducted, the availability of trained professionals, and the growing demand for novel drugs for chronic disease treatment propel market growth.

europe-clinical-trial-management-market

To learn more about this report, request a free sample copy

The Europe clinical trial management market growth assessment includes the analysis of the United Kingdom, Sweden, Hungary, Spain, Denmark, Germany, France, Italy, Russia, and Rest of Europe. The United Kingdom has a leading genomics industry, including research in genetics, biochemical, and human DNA. The government efforts in integrating genomics with healthcare have benefited biotech companies. For instance, the NHS has launched a genomic medicine service set to include human genomics data into standard healthcare. Further, commercial clinical research trends have been stable in recent years. The UK falls short in terms of Phase III clinical trials in comparison to other European countries. As a result, the government has extended its support to the launch of ‘High Throughput Centers’ to propel Phase II and III trials. Such developments promote market growth in the UK.

France is one of the complex markets with regard to the commercialization of pharmaceutical products. It has the highest consumption of medicines per capita globally. It is also the second-largest market in Europe for medical care. In 2016, the country announced the development of a large-scale genome sequencing operation in healthcare. Such factors are projected to contribute to the France market growth.

Bioclinica is an integrated clinical life science solutions provider. It delivers insights into clinical trial development. The company also offers clinical adjudication, trial supply management & optimization, clinical trial management software, etc. It has an extensive global presence and a strong product portfolio in the clinical trial management system. It is headquartered in Princeton, New Jersey, United States.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • PARENT MARKET ANALYSIS – HEALTHCARE
      • MARKET SCOPE
      • KEY DRIVERS
        • OUTSOURCING OF CLINICAL TRIALS
        • GROWING NUMBER OF CLINICAL TRIALS
        • AWARENESS REGARDING THE BENEFITS OF USING CTM SOFTWARE
        • INCIDENCES OF CHRONIC DISEASES
        • RESEARCH & DEVELOPMENT
      • KEY RESTRAINTS
        • SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
        • COST OF IMPLEMENTATION
        • SECURITY CONCERNS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY END-USER
      • PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
      • CLINICAL RESEARCH ORGANIZATIONS
      • HEALTHCARE PROVIDERS
    3. MARKET BY PRODUCT TYPE
      • ENTERPRISE-BASED CTM
      • SITE-BASED CTM
    4. MARKET BY DEPLOYMENT MODEL
      • WEB-BASED DEPLOYMENT
      • ON-PREMISE DEPLOYMENT
      • CLOUD-BASED DEPLOYMENT
    5. MARKET BY COMPONENT
      • SOFTWARE
      • HARDWARE
      • SERVICES
    6. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • DENMARK
          • HUNGARY
          • SWEDEN
          • SPAIN
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
      • COMPANY PROFILES
        • ADVARRA (FORTE RESEARCH SYSTEMS INC)
        • ARISGLOBAL LLC
        • BIOCLINICA INC
        • BIO-OPTRONICS INC
        • IBM CORPORATION
        • MEDIDATA SOLUTIONS INC
        • MEDNET SOLUTIONS INC
        • ORACLE CORPORATION
        • PAREXEL INTERNATIONAL CORPORATION
        • VEEVA SYSTEMS INC

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – CLINICAL TRIAL MANAGEMENT

    TABLE 2: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 3: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 4: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 6: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 8: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 9: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 10: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 11: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 12: KEY PLAYERS OPERATING IN EUROPE CLINICAL TRIAL MANAGEMENT MARKET

    TABLE 13:  LIST OF MERGERS & ACQUISITIONS

    TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 15: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

    LIST OF FIGURES 

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

    FIGURE 6: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)

    FIGURE 7: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2022-2030 (IN $ MILLION)

    FIGURE 8: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2022-2030 (IN $ MILLION)

    FIGURE 9: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021

    FIGURE 10: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2022-2030 (IN $ MILLION)

    FIGURE 11: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2022-2030 (IN $ MILLION)

    FIGURE 12: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2021

    FIGURE 13: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)

    FIGURE 14: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2022-2030 (IN $ MILLION)

    FIGURE 15: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)

    FIGURE 16: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2021

    FIGURE 17: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2022-2030 (IN $ MILLION)

    FIGURE 18: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2022-2030 (IN $ MILLION)

    FIGURE 19: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)

    FIGURE 20: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 21: UNITED KINGDOM CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 22: GERMANY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 23: FRANCE CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 24: ITALY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 25: RUSSIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 26: DENMARK CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 27: HUNGARY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 28: SWEDEN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 29: SPAIN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 30: REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • DENMARK
          • HUNGARY
          • SWEDEN
          • SPAIN
          • REST OF EUROPE
    1. MARKET BY END-USER
      • PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
      • CLINICAL RESEARCH ORGANIZATIONS
      • HEALTHCARE PROVIDERS
    2. MARKET BY PRODUCT TYPE
      • ENTERPRISE-BASED CTM
      • SITE-BASED CTM
    3. MARKET BY DEPLOYMENT MODEL
      • WEB-BASED DEPLOYMENT
      • ON-PREMISE DEPLOYMENT
      • CLOUD-BASED DEPLOYMENT
    4. MARKET BY COMPONENT
      • SOFTWARE
      • HARDWARE
      • SERVICES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type